Colgate-Palmolive Company $CL Shares Bought by Massachusetts Wealth Management

Massachusetts Wealth Management raised its position in Colgate-Palmolive Company (NYSE:CL) by 1.8% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 12,822 shares of the company’s stock after purchasing an additional 225 shares during the quarter. Massachusetts Wealth Management’s holdings in Colgate-Palmolive were worth $1,166,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Personal CFO Solutions LLC acquired a new position in Colgate-Palmolive in the 1st quarter valued at about $285,000. Vision Capital Management Inc. acquired a new position in Colgate-Palmolive in the 1st quarter valued at about $322,000. Autumn Glory Partners LLC boosted its holdings in Colgate-Palmolive by 67.4% in the 1st quarter. Autumn Glory Partners LLC now owns 8,905 shares of the company’s stock valued at $851,000 after purchasing an additional 3,586 shares during the last quarter. Financial Gravity Asset Management Inc. acquired a new position in shares of Colgate-Palmolive in the 1st quarter worth approximately $2,166,000. Finally, Penserra Capital Management LLC lifted its holdings in shares of Colgate-Palmolive by 398.6% in the 1st quarter. Penserra Capital Management LLC now owns 10,651 shares of the company’s stock worth $997,000 after acquiring an additional 8,515 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock opened at $77.96 on Thursday. The firm has a market cap of $63.01 billion, a PE ratio of 21.90, a price-to-earnings-growth ratio of 4.11 and a beta of 0.34. Colgate-Palmolive Company has a 52-week low of $77.09 and a 52-week high of $102.61. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 6.79. The company’s 50 day moving average is $82.79 and its two-hundred day moving average is $88.08.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.89 by $0.03. The company had revenue of $5.11 billion for the quarter, compared to analyst estimates of $5.03 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The firm’s quarterly revenue was up 1.0% on a year-over-year basis. During the same period in the prior year, the business earned $0.91 EPS. On average, research analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 17th will be given a $0.52 dividend. The ex-dividend date of this dividend is Friday, October 17th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.7%. Colgate-Palmolive’s dividend payout ratio is currently 58.43%.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on CL shares. The Goldman Sachs Group decreased their price objective on shares of Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating on the stock in a report on Thursday, October 2nd. Wells Fargo & Company decreased their price objective on shares of Colgate-Palmolive from $83.00 to $80.00 and set an “underweight” rating on the stock in a report on Thursday, September 25th. UBS Group decreased their price objective on shares of Colgate-Palmolive from $99.00 to $92.00 and set a “buy” rating on the stock in a report on Wednesday. JPMorgan Chase & Co. decreased their price objective on shares of Colgate-Palmolive from $99.00 to $95.00 and set an “overweight” rating on the stock in a report on Monday, August 4th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Colgate-Palmolive in a report on Wednesday. Eight research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and an average price target of $93.23.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.